Your browser doesn't support javascript.
loading
SERS-Based Evaluation of the DNA Methylation Pattern Associated With Progression in Clonal Leukemogenesis of Down Syndrome.
Moisoiu, Vlad; Sas, Valentina; Stefancu, Andrei; Iancu, Stefania D; Jurj, Ancuta; Pasca, Sergiu; Iluta, Sabina; Zimta, Alina-Andreea; Tigu, Adrian B; Teodorescu, Patric; Turcas, Cristina; Blag, Cristina; Dima, Delia; Popa, Gheorghe; Arghirescu, Smaranda; Man, Sorin; Colita, Anca; Leopold, Nicolae; Tomuleasa, Ciprian.
Afiliação
  • Moisoiu V; Faculty of Physics, Babes-Bolyai University, Cluj-Napoca, Romania.
  • Sas V; Department of Hematology, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.
  • Stefancu A; Department of Pediatrics, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.
  • Iancu SD; Faculty of Physics, Babes-Bolyai University, Cluj-Napoca, Romania.
  • Jurj A; Faculty of Physics, Babes-Bolyai University, Cluj-Napoca, Romania.
  • Pasca S; Research Center for Functional Genomics and Translational Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.
  • Iluta S; Department of Hematology, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.
  • Zimta AA; Department of Hematology, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.
  • Tigu AB; Medfuture Research Center for Advanced Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.
  • Teodorescu P; Medfuture Research Center for Advanced Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.
  • Turcas C; Department of Hematology, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.
  • Blag C; Department of Hematology, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.
  • Dima D; Department of Hematology, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.
  • Popa G; Department of Hematology, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.
  • Arghirescu S; Department of Pediatrics, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.
  • Man S; Department of Pediatrics, Victor Babes University of Medicine and Pharmacy, Timisoara, Romania.
  • Colita A; Department of Pediatrics, Louis Turcanu Emergency Hospital for Children, Timisoara, Romania.
  • Leopold N; Department of Pediatrics, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.
  • Tomuleasa C; Department of Pediatrics, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania.
Front Bioeng Biotechnol ; 9: 703268, 2021.
Article em En | MEDLINE | ID: mdl-34368097
ABSTRACT
Here we show that surface-enhanced Raman scattering (SERS) analysis captures the relative hypomethylation of DNA from patients with acute leukemia associated with Down syndrome (AL-DS) compared with patients diagnosed with transient leukemia associated with Down syndrome (TL-DS), an information inferred from the area under the SERS band at 1005 cm-1 attributed to 5-methycytosine. The receiver operating characteristic (ROC) analysis of the area under the SERS band at 1005 cm-1 yielded an area under the curve (AUC) of 0.77 in differentiating between the AL-DS and TL-DS groups. In addition, we showed that DNA from patients with non-DS myeloproliferative neoplasm (non-DS-MPN) is hypomethylated compared to non-DS-AL, the area under the SERS band at 1005 cm-1 yielding an AUC of 0.78 in separating between non-DS-MPN and non-DS-AL. Overall, in this study, the area of the 1005 cm-1 DNA SERS marker band shows a stepwise decrease in DNA global methylation as cells progress from a pre-leukemia to a full-blown acute leukemia, highlighting thus the potential of SERS as an emerging method of analyzing the methylation landscape of DNA in the context of leukemia genesis and progression.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Bioeng Biotechnol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Romênia

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Bioeng Biotechnol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Romênia